CASEY WEITZEL: Open Payments
NPI 1811658347 · CHARLEVOIX, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 55 payments from 11 companies in 2025. Trend: 2023 $1,170 · 2024 $1,149 · 2025 $1,281
Food & beverage: $1,182Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $376 |
| Novartis Pharmaceuticals Corporation | 14 | $244 |
| E.R. Squibb & Sons, L.L.C. | 6 | $204 |
| Arcutis Biotherapeutics, Inc. | 4 | $144 |
| Janssen Biotech, Inc. | 3 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $72 |
| Galderma Laboratories, L.P. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Incyte Corporation | 1 | $29 |
| UCB, Inc. | 1 | $25 |
Products named: SKYRIZI, COSENTYX, Sotyktu, Zoryve, RINVOQ, TREMFYA, ILUMYA, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
